Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Completes $7.4 Million Equity Financing

Premium

PALO ALTO, Calif.--Caliper Technologies, manufacturer of laboratory-on-a-chip technology, raised an additional $7.4 million in equity financing to accelerate development of the company's proprietary LabChip technology platform for ultrahigh-throughput chemical and biochemical research and analysis. The company has raised over $40 million to advance the experimental platform. Investors this round included Lombard Odier, Genesis Merchant Group, and Hewlett-Packard. The company said the financing would allow it to expand applicability of the LabChip platform rapidly in the areas of ultrahigh-throughput drug development, genomics, proteomics, and clinical diagnostics. The LabChip integrates microscopic versions of biochemical pumps, valves, test tubes, reactors, extractors, and separation systems to manage complex laboratory processes on a microchip.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.